These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 3359477)
1. [Quinolones--increased possibilities of antibacterial therapy]. Novácek L Cas Lek Cesk; 1988 Feb; 127(6):184-7. PubMed ID: 3359477 [No Abstract] [Full Text] [Related]
2. [Fluoroquinolones. 1. Their chemical structure, mechanism of action and antibacterial activity]. Stahlmann R; Kemmerich B; Lode H Dtsch Med Wochenschr; 1988 Apr; 113(16):648-51. PubMed ID: 2834166 [No Abstract] [Full Text] [Related]
3. [Fluoroquinolones]. Baykal M; Akalin E Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120 [TBL] [Abstract][Full Text] [Related]
4. The quinolones and dermatologic practice. Parish LC; Witkowski JA Int J Dermatol; 1986; 25(6):351-6. PubMed ID: 3531041 [No Abstract] [Full Text] [Related]
5. Quinolones: a review. Christenson-Bravo B; Quintana MC Bol Asoc Med P R; 1987 Oct; 79(10):411-4. PubMed ID: 3328614 [No Abstract] [Full Text] [Related]
6. [Quinolones in 1988]. Brun-Buisson C Rev Prat; 1988 Mar; 38(8):493-500. PubMed ID: 3375770 [No Abstract] [Full Text] [Related]
7. New pyrazolinylanilinoquinolines and other related products of possible antibacterial activity. Kamel M; Nabih I; Gadalla KZ; Ashour MM Pharmazie; 1986 Jan; 41(1):55-6. PubMed ID: 3960951 [No Abstract] [Full Text] [Related]
8. Mechanism of plasmodial drug resistance. Natarajan PN; Lan NT Southeast Asian J Trop Med Public Health; 1972 Sep; 3(3):343-6. PubMed ID: 4569026 [No Abstract] [Full Text] [Related]
9. [Synthesis and antibacterial activity of azomethino and aminomethyl derivatives of 2,7-dimethoxyquinolin-3-carboxaldehyde]. Gatti R; Cavrini V; Cesaroni MR; Roveri P; Brigidi P Boll Chim Farm; 1985 Feb; 124(2):69-74. PubMed ID: 4015868 [No Abstract] [Full Text] [Related]
10. [New antibacterial antibiotics and chemotherapeutic agents]. Krcméry V; Antal M Vnitr Lek; 1986 Aug; 32(8):806-13. PubMed ID: 3765419 [No Abstract] [Full Text] [Related]
11. [Quinolones]. van Ketel RJ Ned Tijdschr Geneeskd; 1987 Aug; 131(34):1467-9. PubMed ID: 3658019 [No Abstract] [Full Text] [Related]
12. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates. Xicota MA; Coll R; Esteve M; Moros M; Parés J Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242 [TBL] [Abstract][Full Text] [Related]
13. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1- and 3-acetylisoquinoline and related compounds as inhibitors of clinically significant bacteria in vitro. Dobek AS; Klayman DL; Dickson ET; Scovill JP; Oster CN Arzneimittelforschung; 1983; 33(11):1583-91. PubMed ID: 6686454 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Stroman DW; Dajcs JJ; Cupp GA; Schlech BA Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308 [TBL] [Abstract][Full Text] [Related]
16. Gentamicin: antibacterial activity, clinical pharmacology and clinical applications. Finland M Med Times; 1969 Dec; 97(12):161-74. PubMed ID: 4904180 [No Abstract] [Full Text] [Related]
17. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Wolfson JS; Hooper DC Antimicrob Agents Chemother; 1985 Oct; 28(4):581-6. PubMed ID: 3000292 [No Abstract] [Full Text] [Related]